2nd Liver Interventional
Oncology Meeting
5 - 7 October 2023
Ljubljana, Slovenia
2nd Liver Interventional
Oncology Meeting
5 - 7 October 2023
Ljubljana, Slovenia
Welcome
Dear colleagues, friends and associates,
I am pleased to invite you to the 2nd Liver Interventional Oncology meeting with international participation – LIO2023, organized by the Slovenian Association of Radiology in cooperation with the radiology department of the Faculty of Medicine Ljubljana and ERA Institute. The event will be held at the Cankar Hall congress and culture center in Ljubljana, Slovenia. Meeting will be held in English.
Interventional oncology has emerged as the fourth pillar of liver cancer therapy alongside medical, surgical, and radiation oncology care, and is the youngest and fastest-growing offshoot of interventional radiology. Our aim is to organize an interdisciplinary scientific event with lectures and delegates from different clinical professions involved in the treatment of liver lesions. The meeting will include international and Slovenian speakers, educational hands-on workshops, and satellite symposiums, with a focus on providing established therapies, the latest research, and the newest technologies.
This meeting will be one of the largest gatherings dedicated to liver interventional oncology in the Adriatic region. It is intended for specialists and residents in radiology, oncology, gastroenterology, surgery, radiation oncology, nuclear medicine, and other branches of medicine, as well as nurses, radiological technologists, and students. We invite all interested parties to actively participate and submit abstract in a timely manner.
We believe that this event will provide a unique opportunity to learn from leading experts in the field, share knowledge and experience, and network with colleagues from around the world. We look forward to welcoming you to Ljubljana for LIO2023.
For more details please get in touch with us.
Sincerely,
Assoc. Prof. Peter Popovič, MD, PhD
Board President, LIO2023
Board President of Abdominal Radiology Section, Slovenian Association of Radiology
Faculty
prof. Borut Štabuc, MD, PhD; Slovenia
prof. Djordjije Šaranović, MD, PhD; Serbia
prof. Irene Bargelini, MD, PhD; Italy
prof. Janja Ocvirk, MD, PhD; Slovenia
prof. Jens Ricke, MD, PhD; Germany
prof. Laura Crocetti, MD, PhD; Italy
prof. Maarten Smits, MD, PhD; Netherlands
prof. Maciej Pech, MD, PhD; Germany
prof. Matjaž Bunc, MD, PhD; Slovenia
prof. Aleš Tomažič, MD, PhD, Slovenia
prof. Marco Van Strijan, MD, PhD, Netherlands
prof. Okan Akhan, MD, PhD; Turkey
prof. Roberto Iezzi, MD, PhD; Italy
prof. Sanja Stojanović, MD, PhD; Serbia
prof. Stojan Potrč, MD, PhD; Slovenia
prof. Tajana Filipec Kanižaj, MD, PhD; Croatia
prof. Vinko Vidjak, MD, PhD; Croatia
prof. Thierry de Baere, MD, PhD; France
prof. Cüneyt Türkmen, MD, PhD; Turkey
assoc. prof. Blaž Trotovšek, MD, PhD; Slovenia
assoc. prof. Jelena Kovač, MD, PhD; Serbia
assoc. prof. Peter Popovič, MD, PhD; Slovenia
assoc. prof. Roberto Luigi Cazzato, MD, Ph D; France
assist. prof. Ana Marija Alduk, MD, PhD; Croatia
assist. prof. Arpad lvanecz, MD, PhD; Slovenia
assist. prof. Luka Ležaič MD, PhD; Slovenia
assist. prof. Maja Marolt Mušič, MD, PhD; Slovenia
assist. prof. Mihailo Djokić, MD, PhD; Slovenia
assist. prof. Nejc Mekiš, PhD; Slovenia
assist. prof. Aleksandar Gjoreski, MD, PhD, Macedonia
assist. prof. Miran Jeromel, MD, PhD, Slovenia
assist. prof. Otmar Rubin, Md, PhD, Croatia
assist. mag Ajra Šečerov, MD, Slovenia
assist. Alojzij Šmid, MD, PhD; Slovenia
assist. Rok Dežman, MD, PhD; Slovenia
asist. Miha Petrič, MD, Slovenia
Helga Serič Milič, MD, PhD, Croatia
Erik Brecelj, MD, PhD; Slovenia
Vladimir Cvetić, MD, PhD; Serbia
Aleksandar Bojanović, MD; Serbia
Davor Mrda, MD; Serbia
Gašper Boltežar, MD; Slovenia
Luka Novosel MD; Croatia
Marija Ribnikar, MD; Slovenia
Miha Štabuc, MD; Slovenia
Sanjo Finderle, MD; Slovenia
Kristjan Lorenčič; Slovenia
Lisa Loskarn, Austria
Pierleone Lucatelli, MD, PhD; Italy
Nikos Ptohis, MD, PhD; Greece
Organisers
Slovenian Association of Radiology
Radiology department, Faculty of Medicine Ljubljana
ERA Institute
Slovenian Association of Radiographers
Important Information
Meeting organisers
Slovenian Association of Radiology
Radiology department, Faculty of Medicine Ljubljana
ERA Institute
Slovenian Association of Radiographers
Organising committee
LIO 2023 President:
Peter Popovič
LIO 2023 Board:
Borut Štabuc, Rok Dežman, Sanja Stojanović, Vinko Vidjak, Ana Marija Alduk, Blaž Trotovšek, Nejc Mekiš
Venue
Cankar Hall congress and culture center in Ljubljana, Prešernova cesta 10, Slovenia.
CE Credits
Credit points given by Medical Chamber of Slovenia: TBA
Registration Fee
Specialist:
€300.00 (VAT included).
Students, residents, nurses, radiological engineers, industry:
€200.00 (VAT included).
Fee free:
Invited speakers and retired physicians
*registration fee includes: access to live sessions, industry booths, book of abstracts
Contact
Contact person for registration:
Nuša Tomšič
info@lio2023.com
Instructions for presentations
The presentations must be prepared in Power Point in English. The presentation time is limited to 15 or 20 minutes. The official language is English.
Instructions for the Book of Abstracts
Abstract submission will be opened on April 15th, 2023. The abstract submission deadline is June 1st, 2023.
Programme
DAY 1
Thursday, October 5th
Registration: 8.00-8.40
Session: Liver lesions 8.45 – 10.15
Session Chair: Okan Akhan, Djordije Šaranovič, Ana Marija Alduk
8.45 – 9.00 Potentials to optimize patient workflows in liver disease – Lisa Loskarn (satellite Siemens)
9.05 – 9.20 Imaging diagnostics of HCC LIRADS and beyond – Jelena Kovač (satellite Bayer)
9.25 – 9.40 Imaging of liver metastases – Maja Marolt Mušič
9.45 – 10.00 Biopsy of liver lesions – Ana Marija Alduk
10.00 – 10.10 Roundtable discussion
10.15 – 10.45 Coffee Break
Session: Satellite Symposium – 10.45 – 12.10
Session Chair: Bunc Matjaž, Rok Dežman, Luigi Roberto Cazzato
10.45 – 11.00 Pulmonary Embolism Treatment with Mechanical Thrombectomy Lytic free approach: FlowTriever can make a difference for patient outcome – Nikos Ptohis (Inari Medical)
11.05 – 11.20 Balloon assisted liver directed therapy: is it time to change – Pierleone Lucatelli (Embolx)
11.25 – 11.40 Advanced image guidance for liver tumor ablation and embolization – Marco Van Strijen (Philips)
11.45 – 12.00 Percutaneous image guided electrochemotherapy of hepatocellular carcinoma: technological advancement – Rok Dežman
12.00 – 12.10 Discussion
12.10 – 12.30 Coffee Break
Session: Intrahepatic Cholangiocarcinoma – 12.30 – 14.10
Session Chair: Maciej Pech, Arpad Ivanecz, Roberto Cazzato
12.30 – 12.45 Cholangiocarcinoma: current guidelines and systemic treatment – Gašper Boltežar (satellite Astra Zeneca)
12.45 – 13.00 Cholangiocarcinoma: systemic treatment – Alojz Šmid (satellite Genesis)
13.05 – 13.20 Cholangiocarcinoma: the role of surgery – Miha Petrič
13.25 – 13.40 Cholangiocarcinoma: the role of ablation – Okan Akhan
13.45 – 14.00 Cholangiocarcinoma: the role of TACE&SIRT – Maciej Pech
14.00 – 14.10 Roundtable Discussion
14.10 – 15.00 Lunch Break
Session: Colorectal liver metastasis – 15.00 – 16.35
Session Chair: Ocvirk Jana, Roberto Iezzi, Erik Brecelj, Stojan Potrč
15.00 – 15.15 Colorectal liver metastasis: Current guidelines and systemic treatment – Jana Ocvirk
15.20 – 15.35 Colorectal liver metastasis: the role of SBRT – Ajra Šečerev
15.40 – 16.00 Colorectal liver metastasis: the role of interventional oncology – Roberto Iezzi
16.05 – 16.20 PVE and SIRT to Impact Liver Volume: When and How – Maciej Peck
16.25 – 16.35 Roundtable Discussion
16.35 – 17.00 Coffee Break
Session: Liver transplatation – 17.00 – 18.20
Session Chair: Marija Ribnikar, Blaž Trotovšek, Vinko Vidjak
17.00 – 17.15 Liver transplantation in hepatocellular carcinoma after tumour downstaging – Tajana Filipec Kanižaj
17.15 – 17.25 Liver transplantation in hepatocellular carcinoma – Mojca Ribnikar
17.25 – 17.40 Bridging therapies for patients with hepatocellular carcinoma awaiting liver transplantation – Rok Dežman
17.40 – 17.55 Interventional radiology management of biliary complication after liver transplantation – Miha Štabuc
17.55 – 18.10 Interventional radiology management of vascular complication after liver transplantation – Vinko Vidjak
18.10 – 18.20 Roundtable discussion
Poster Session: 18.20 – 18.40
Session Chair: Rok Dežman
1. Inari FlowTriever System in patient with breast carcinoma and high-risk pulmonary embolism – Nika Tomažin, Ana Leben Žlajpah, Peter Popović
2. Long term survival of patients with large HCC treated with Selective internal radiation therapy (SIRT) and subsequent surgical resection – David Popovič, Cene Jerele
3. Percutaneous microwave ablation of hepatic reactive lymphoid hyperplasia: A case report – Maša Sever, Peter Popovič, Špela Koršič
4. Portal vein embolization and liver venous deprivation before major hepatectomy – Maša Sever, Rok Dežman, Peter Popovič
5. Long-term survival of a patient with a large infiltrative hepatocellular carcinoma after multimodality treatment – Jure Valentinčič, Lara Anja Lešnik Zupan, Peter Popovič
6. Complete response in large HCC lesion treated with balloon- DEBTACE and multi-probe TATO microwave ablation – Polona Vihtelič, Rok Dežman, Peter Popovič
7. The Range of Ophthalmic Manifestations Associated with Durvalumab – Nika Vrabic, Ana Fakin, Polona Jaki Mekjavic, Urska Janzic, Martina Vrankar, Nataša Vidovič Valentinčič
8. Long-term survival of a patient with liver metastases from clear cell gastric adenocarcinoma after multimodality treatment including interventional oncology techniques – Vesna Jugovec, Peter Popovič
9. Downstaging of unresectable colorectal liver metastasis using DEBIRI TACE- a case report – Jovana Lalatović, Nemanja Kraišnik, Matija Miljević, Filip Lukić, Davor Mrda
10. Locoregional treatments for downstaging of metastatic HCC – a bridge to a successful surgery, a case report – Jovana Lalatović, Nemanja Kraišnik, Matija Miljević, Filip Lukić, Davor Mrda
11. Changes after RFA of hepatic tumors: normal vs abnormal CT signs – Živa Miriam Geršak, Rok Dežman
12. Comparison of ablation volume in microwave ablation versus single session microwave ablation + TACE – Rūta Mikšytė, Miha Štabuc, Peter Popovič, Rok Dežman
13. Evaluation of lesion characteristics after electrochemotherapy of hepatocellular carcinoma – Tim Velkavrh, Rok Dežman
14. Liver metastases of a neuroendocrine tumours – the role of interventional radiology – Andrej Čarni, Rok Dežman
Thursday Parallel Schedule
15.00 – 16.30 Symposium of Radiological Technologists and Nurses – part I
Session Chair: Nejc Mekiš, Tomislav Stanković, Andrej Sirnik
15.00 – 15.15 CT Techniques, protocols, and advancements in liver lesions – Jure Mišič
15.20 – 15.35 Gadoxetic acid – enhanced MRI liver imaging – Andrej Sirnik
15.40 – 15.55 The role of nurses in interventional oncology – Kristjan Lorenčič
16.00 – 16.15 Drug eluting chemoembolization – David Vrhovec
16.15 – 16.30 Selective internal radiation therapy (SIRT) – Radmila Bjelajac
16.30 – 17.00 Coffe break
17.00 – 19.00 Symposium of Radiological Tehnologists and Nurses – part II
Session Chair: Josip Pahlina, Matevž Čadej
17.00 – 17.15 Analysis of the ferquency and severity of radiation-induced skin injuries from interventional radiology procedures – Miha Kovačič
17.20 – 17.35 The differences in effectiveness of protective aprons in interventional radiology – Almir Halilović
17.40 – 17.55 Advanced image guidance in liver interventional oncology – Matevž Čadej
18.00 – 18.15 Ablation of liver lesions – Josip Pahlina
18.20 – 18.35 The role of TRs/RTTs in the management of interventional radiotherapy for upper GI tract – Patrizia Cornacchione
18.35 – 19.00 Discussion
DAY 2
Friday,October 6th
Session: Interventional oncology – Current Status and Future Prospective – part I – 8.30 – 10.00
Session Chair: Popovič Peter, Borut Štabuc, Jens Ricke
08.30 – 08.50 Y- 90 Radioembolization: Current Status and Future Prospective – Jens Ricke
08.55 – 09.15 Holmium-166 Radioembolization: Current Status and Future Prospective – Maarten Smits (satellite Terumo)
09.20 – 09.40 Y- Role of Dosimetry in Selective Internal Radiation Therapy (SIRT) in the Treatment of Hepatic Malignancies – Cüneyt Türkmen (satellite Boston)
09.45 – 09.55 Discussion
10.00 – 10.30 Opening ceremony – Welcoming speech and introduction
10.30 – 10.45 Coffee Break
Session: Interventional oncology – Current Status and Future Prospective – part II – 10.50 -12.15
Session Chair: Rok Dežman, Laura Croceti, Gašper Boltežar, Miha Petrič
10.50 – 11.10 Ablation: Current Status and Future Prospective – Laura Croceti
11.15 – 11.35 Chemoembolization: Current Status and Future Prospective – Irene Bargelini
11.40 – 12.00 Locoregional therapies in the era of molecular and immune treatments – Thierry de Baere
12.05 – 12.15 Discussion
12.15 – 12.30 Coffee Break
Session: Liver metastatic neuroendocrine tumors – 12.30 – 13.40
Session Chair: Irene Bargelini, Alojz Šmid, Aleš Tomažič, Sanja Stojanovič
12.30 – 12.45 Liver metastatic neuroendocrine tumors: Current guidelines and treatment options – Alojz Šmid
12.50 – 13.05 Liver metastatic neuroendocrine tumors: nuclear medicine – Luka Ležaič
13.10 – 13.30 Liver metastatic neuroendocrine tumors: chemoembolization and radioembolisation treatment strategies – Irene Bargellini
13.30 – 13.40 Discussion
13.40 – 14.40 Lunch Break
Session: Hepatoccelular carcinoma – 14.40 – 17.00
Session Chair: Popovič Peter, Blaž Trotovšek, Thierry de Baere
14.40 – 15.00 HCC: current guidelines and systemic treatment – Gašper Boltežar (satellite Roche)
15.05 – 15.20 Local ablation – current state and room for improvement – Laura Croceti
15.25 – 15.40 Surgical resection and transplantation – what is the role in 2023 – Blaž Trotovšek
15.45 – 16.00 Patient selection for chemoembolization – Peter Popovič
16.05 – 16.20 SIRT – what is the ideal patient and its role in advanced disease – Jens Ricke
16.25 – 16.40 Recent Clinical trials in HCC – Thierry de Baere
16.40 – 16.55 Discussion
17.00 – 17.30 Coffee Break
Scientific Session/ Alpe – Adria region experience – 17.30 – 19.00
Session Chair: Rok Dežman, Miran Jeromel, Luka Novosel, Aleksander Gjoreski
17.30 – 17.40 Hybrid treatment in liver tumors: What can we expect from SBRT – Otmar Rubin
17.40 – 17.50 Liver IO in Macedonia – Aleksander Gjoreski
17.50 – 18.00 Liver IO in Serbia – Aleksandar Bojanovič
18.00 – 18.10 Liver ablation in Croatia – Luka Novosel
18.10 – 18.20 Liver IO in UKC Maribor – Silva Breznik
18.20 – 18.30 Sedation and anesthesia for interventional oncology – Lužar Tomaž
18.30 – 18.40 Percutaneous ablation of liver lesions in UMC Ljubljana – Rok Dežman, Miha Štabuc, Peter Popovič
18.40 – 18.50 Safety and efficacy of drug-eluting microspheres chemoembolization under cone beam computed tomography control in patients with early and intermediate stage hepatocellular carcinoma – Lara Anja Lesnik Zupan, Nastja Levasič, Miha Štabuc, Rok Dežman, Peter Popovič
18.50 – 19.00 Balloon-occluded transcatheter arterial chemoembolization for HCC – Helga Serić Milić
19.00 – 19.10 Single-institution experience with selective Yttrium-90 internal radiation therapy in HCC patients – Diana Vozlič, Miha Štabuc, Rok Dežman, Lojze Šmid, Peter Popovič
19.10 – 19.20 Discussion
Friday Parallel Schedule
15.00 – 17.00 h Symposium of Radiological Technologists and Nurses – part III
Session Chair: Adnan Šehić, Nejc Mekiš, Kristjan Lorenčič
15.00 – 15.20 CT guided liver biopsy – radiographer role and case studies – Ognjen Ačimović
15.25 – 15.45 Interventional oncology of kidney – Kristjan Lorenčič
15.50 – 16.05 Cryoablation in kidney tumors – Matevž Robnik
16.10 – 16.25 MRI/US fusion-guided prostate biopsy – Saša Cerar
16.25 – 16.30 Discussion
16.30 – 17.00 Coffe break
17.30 – 19.00 Symposium of Radiological Technologists and Nurses – part IV
17.00 – 17.35 Protocols in cardiac MRI – Rok Us
17.40 – 17.55 Isolated Limb Perfusion (ILP) in a patient with myxoid liposarcoma (MLPS) – a case report – Jelena Perić
18.00 – 18.15 Hybrid treatment of liver lesions – Milan Gržan
18.20 – 18.35 Hybrid treatment of liver lesions – SBRT – Jelena Trajković
18.35 – 19.00 Discussion
DAY 3
Saturday,October 7th
Scientific Session/ Alpe – Adria region experience 10.00 – 11.30
Session Chair: Miha Štabuc, Silva Breznik, Sanjo Finderle, Davor Mrda
10.00 – 10.15 Transradial approach for transarterial chemoembolization – Vladimir Cvetič (satellite Terumo)
10.15 – 10.25 Survival of patients with unresectable cholangiocarcinoma treated with DEBDOX TACE – Miha Štabuc, Rok Dežman, Peter Popovič
10.25 – 10.35 Complete response of Hepatocellular Carcinoma in a patient with BCLC-C stage treated with a combination of radioembolization, systemic immunotherapy and surgery – a case report – Polona Vihtelič, Lojze Šmid, Peter Popovič
10.35 – 10.45 Locoregional therapies in the management of liver lesions – our experience – Davor Mrda
10.45 – 10.55 Prognostic factors for overall survival and safety of DEBIRI TACE in patients with colorectal liver metastases – Maja Šljivič, Rok Dežman, Peter Popovič
10.55 – 11.05 Safety and efficacy of transarterial chemoembolization using idarubicin in patients with hepatocellular carcinoma –
Špela Koršič, Peter Popovič
11.05 – 11.15 The changes of angiogenic factors expression after DEBDOX TACE in patients with hepatocellular carcinoma – Čarni Andrej, Joško Osredkar, Peter Popovič
11.15 – 11.30 Cryoablation: Current Status and Future Prospective – Luigi Roberto Cazzato
11.30 – 11.40 Discussion
11.40 – 11.50 Closing ceremony
Contact / Submit Abstract
Sponsors
Check out
Venue
Cankar Hall
Congress and culture center in Ljubljana
Prešernova cesta 10
Ljubljana, Slovenia